Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Health Serv Res ; 20(1): 341, 2020 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-32316963

RESUMEN

BACKGROUND: The End TB Strategy calls for global scale-up of preventive treatment for latent tuberculosis infection (LTBI), but little information is available about the associated human resource requirements. Our study aimed to quantify the healthcare worker (HCW) time needed to perform the tasks associated with each step along the LTBI cascade of care for household contacts of TB patients. METHODS: We conducted a time and motion (TAM) study between January 2018 and March 2019, in which consenting HCWs were observed throughout a typical workday. The precise time spent was recorded in pre-specified categories of work activities for each step along the cascade. A linear mixed model was fit to estimate the time at each step. RESULTS: A total of 173 HCWs in Benin, Canada, Ghana, Indonesia, and Vietnam participated. The greatest amount of time was spent for the medical evaluation (median: 11 min; IQR: 6-16), while the least time was spent on reading a tuberculin skin test (TST) (median: 4 min; IQR: 2-9). The greatest variability was seen in the time spent for each medical evaluation, while TST placement and reading showed the least variability. The total time required to complete all steps along the LTBI cascade, from identification of household contacts (HHC) through to treatment initiation ranged from 1.8 h per index TB patient in Vietnam to 5.2 h in Ghana. CONCLUSIONS: Our findings suggest that the time requirements are very modest to perform each step in the latent TB cascade of care, but to achieve full identification and management of all household contacts will require additional human resources in many settings.


Asunto(s)
Manejo de Caso , Personal de Salud , Recursos en Salud , Tuberculosis Latente , Adulto , Benin , Canadá , Femenino , Ghana , Humanos , Indonesia , Tuberculosis Latente/diagnóstico , Tuberculosis Latente/terapia , Modelos Lineales , Masculino , Persona de Mediana Edad , Estudios de Tiempo y Movimiento , Vietnam
2.
Int J Tuberc Lung Dis ; 4(4): 340-4, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10777083

RESUMEN

SETTING: The Komfo Anokye Teaching Hospital, Kumasi, Ghana, West Africa. OBJECTIVE: To evaluate simple and commonly used parameters of the acute-phase response as correlates of successful resolution of smear-positive pulmonary tuberculosis (PTB) during drug treatment. DESIGN: Serum C-reactive protein (CRP) concentration, erythrocyte sedimentation rate (ESR), body weight, and blood haemoglobin were measured in human immunodeficiency virus (HIV) negative Ghanaian patients with PTB (n = 15) and in age- and sex-matched healthy controls (n = 15). These parameters were subsequently measured in patients after 1, 2 and 3 months of antituberculosis treatment. Serum concentrations of soluble interleukin-2-receptor-alpha (sCD25) were also measured as a comparative index of resolution of the systemic inflammatory process. RESULTS: Anti-tuberculosis treatment resulted in sputum smear conversion in all 15 patients. After one month of treatment, reductions in serum CRP concentration (>20%) and increases in haemoglobin concentration (>0.4 g/dl) occurred in the majority of patients and correlated with steep reductions in serum levels of sCD25. In contrast, weight loss and elevated ESR were slower to resolve, and were insensitive early markers of response to treatment. CONCLUSION: A fall in serum CRP and a rise in blood haemoglobin are correlates of the initial response to drug treatment of PTB. These parameters may assist in the evaluation of empiric trials of treatment in microbiologically unconfirmed cases of suspected PTB.


Asunto(s)
Reacción de Fase Aguda/etiología , Reacción de Fase Aguda/inmunología , Antituberculosos/uso terapéutico , Sedimentación Sanguínea , Peso Corporal , Proteína C-Reactiva/efectos de los fármacos , Proteína C-Reactiva/metabolismo , Hemoglobinas/análisis , Receptores de Interleucina-2/sangre , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/inmunología , Reacción de Fase Aguda/sangre , Adulto , Biomarcadores/sangre , Estudios de Casos y Controles , Monitoreo de Drogas , Femenino , Ghana , Humanos , Masculino , Reproducibilidad de los Resultados , Esputo/microbiología , Factores de Tiempo , Tuberculosis Pulmonar/complicaciones , Tuberculosis Pulmonar/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA